论文部分内容阅读
目的分析在对重症心功能不全患者治疗中实行抗凝治疗的临床效果。方法 54例重症心功能不全患者采用随机数字表法分为参照组与研究组,各27例。参照组治疗中给予不应用低分子肝素的基础抗心功能不全治疗,研究组治疗过程中给予低分子肝素抗凝治疗,对比分析两组患者治疗后心功能改善情况以及临床治疗效果。结果研究组治疗后总有效率为96.30%,显著优于参照组的74.07%,差异具有统计学意义(P<0.05)。结论在对重症心功能不全患者进行治疗中实行皮下注射低分子肝素抗凝治疗具有显著效果,可以有效改变血栓栓塞症状,改善患者预后,提高治疗效果,值得进一步应用。
Objective To analyze the clinical effect of anticoagulant therapy in the treatment of patients with severe cardiac insufficiency. Methods Fifty-four patients with severe cardiac insufficiency were divided into reference group and study group by random number table, with 27 cases in each group. In the reference group, low-molecular-weight heparin-free basic anti-heart insufficiency was given. The study group was given low-molecular-weight heparin anticoagulant therapy. The improvement of cardiac function and clinical effect were compared between the two groups after treatment. Results The total effective rate of the study group after treatment was 96.30%, significantly higher than the 74.07% of the reference group, the difference was statistically significant (P <0.05). Conclusion In the treatment of patients with severe cardiac insufficiency, subcutaneous injection of low molecular weight heparin anticoagulant therapy has significant effect, which can effectively change the symptoms of thromboembolism, improve the prognosis of patients and improve the therapeutic effect, which is worth further application.